Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Inositol wins 3 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
Top outcomes
Verdict
Probably helps
14 of 21 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Gymnema Sylvestre and Inositol have evidence — compare verdict strength side-by-side.
200-400mg standardized extract (≥25% gymnemic acids) 1-2x daily, or 2-4g dried leaf
with-meals
Standardized extract (≥25% gymnemic acids)
2-4g for general anxiety; 12-18g for OCD/panic
Divided into 2-3 doses, With or without food
Myo-inositol powder (most economical for higher doses)
8-12 weeks
Immediate-2 weeks
8-12 weeks
Days
4-6 weeks
6-12 weeks
3-6 months
First 1-2 weeks
The effect of Gymnema sylvestre supplementation on glycemic control in type 2 diabetes patients: A systematic review and meta-analysis.
Phytotherapy research : PTR (2021) · Meta analysis
Significant reductions in fasting blood glucose and HbA1c versus control
The effects of Gymnema Sylvestre supplementation on lipid profile, glycemic control, blood pressure, and anthropometric indices in adults: A systematic review and meta-analysis.
Phytotherapy research : PTR (2023) · Meta analysis
Reductions in fasting glucose and improvements in lipid profile
A systematic review of Gymnema sylvestre in obesity and diabetes management.
Journal of the science of food and agriculture (2014) · Systematic review
Possible benefits for glycemic control and body weight
Antenatal dietary supplementation with myo-inositol for preventing gestational diabetes
The Cochrane database of systematic reviews (2023) · Meta analysis · n=1319
For the primary neonatal outcomes, only one study measured the risk of a large-for-gestational-age infant and found myo-inositol was associated with both appreciable benefit and harm (RR 1.40, 95% CI 0.65 to 3.02; 1 study, 234 infants; low-certainty evidence).
Inositol Nutritional Supplementation for the Prevention of Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Nutrients (2022) · Meta analysis · n=1321
Pooled results were expressed as relative risk (RR) or mean difference (MD) with a 95% confidence interval (95% CI).
Antioxidants for female subfertility
The Cochrane database of systematic reviews (2020) · Meta analysis · n=7760
Due to the very low-quality of the evidence we are uncertain whether antioxidants improve live birth rate compared with placebo or no treatment/standard treatment (odds ratio (OR) 1.81, 95% confidence interval (CI) 1.36 to 2.43; P < 0.001, I2 = 29%; 13 RCTs, 1227 women).
Based on multiple meta-analyses showing inositol benefits for PCOS including improved menstrual regularity, hormonal parameters, and metabolic markers. Evidence quality varies across studies with some limitations noted in systematic reviews.
AI-estimated from published studies. Interpret as directional guidance.
Inositol has a higher evidence score (7/10 vs 5.5/10) and wins in 3 of 3 categories.
For manage blood sugar, Inositol has a higher relevance score (85 vs 82).
No known interactions between Gymnema Sylvestre and Inositol have been documented in our database. However, always consult a healthcare provider before combining supplements.